Rallybio (RLYB) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to 0.93.
- Rallybio's Equity Ratio rose 393.42% to 0.93 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.93, marking a year-over-year increase of 393.42%. This contributed to the annual value of 0.91 for FY2024, which is 143.18% down from last year.
- Latest data reveals that Rallybio reported Equity Ratio of 0.93 as of Q3 2025, which was up 393.42% from 0.9 recorded in Q2 2025.
- Rallybio's 5-year Equity Ratio high stood at 0.96 for Q1 2023, and its period low was 0.87 during Q2 2024.
- For the 3-year period, Rallybio's Equity Ratio averaged around 0.92, with its median value being 0.92 (2023).
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 825.9% in 2024, then soared by 410.16% in 2025.
- Over the past 3 years, Rallybio's Equity Ratio (Quarter) stood at 0.92 in 2023, then dropped by 1.43% to 0.91 in 2024, then rose by 2.91% to 0.93 in 2025.
- Its Equity Ratio stands at 0.93 for Q3 2025, versus 0.9 for Q2 2025 and 0.93 for Q1 2025.